Literature DB >> 23187866

Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticles.

Pinaki R Desai1, Punit P Shah1, Patrick Hayden2, Mandip Singh1.   

Abstract

PURPOSE: To investigate the percutaneous permeation pathways of cell penetrating peptide modified lipid nanoparticles and oleic acid modified polymeric nanoparticles.
METHODS: Confocal microscopy was performed on skin cultures (EpiDermFT™) for modified and un-modified nanoparticles. Differential stripping was performed following in vitro skin permeation of Ibuprofen (Ibu) encapsulated nanoparticles to estimate Ibu levels in different skin layers and receiver compartment. The hair follicles (HF) were blocked and in vitro skin permeation of nanoparticles was then compared with unblocked HF. The surface modified nanoparticles were investigated for response on allergic contact dermatitis (ACD).
RESULTS: Surface modified nanoparticles showed a significant higher (p < 0.05) in fluorescence in EpiDermFT™ cultures compared to controls. The HF play less than 5% role in total nanoparticle permeation into the skin. The Ibu levels were significantly high (p < 0.05) for surface modified nanoparticles compared to controls. The Ibu levels in skin and receiver compartment were not significantly different when HF were open or closed. Modified nanoparticles showed significant improvement in treatment of ACD compared to solution.
CONCLUSIONS: Our studies demonstrate that increased skin permeation of surface modified nanoparticles is not only dependent on a follicular pathway but also occur through non-follicular pathway(s).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23187866      PMCID: PMC3760706          DOI: 10.1007/s11095-012-0939-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  40 in total

1.  A new method to determine the distribution of a fluorophore in scalp skin with focus on hair follicles.

Authors:  Ylva Y Grams; Joke A Bouwstra
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

2.  Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes.

Authors:  G M El Maghraby; A C Williams; B W Barry
Journal:  J Pharm Pharmacol       Date:  2001-10       Impact factor: 3.765

Review 3.  Drug delivery routes in skin: a novel approach.

Authors:  B W Barry
Journal:  Adv Drug Deliv Rev       Date:  2002-11-01       Impact factor: 15.470

Review 4.  Methods for quantifying intrafollicular drug delivery: a critical appraisal.

Authors:  Victor M Meidan
Journal:  Expert Opin Drug Deliv       Date:  2010-09       Impact factor: 6.648

Review 5.  Biodegradable polymeric nanoparticles as drug delivery devices.

Authors:  K S Soppimath; T M Aminabhavi; A R Kulkarni; W E Rudzinski
Journal:  J Control Release       Date:  2001-01-29       Impact factor: 9.776

Review 6.  Transfollicular drug delivery--is it a reality?

Authors:  Victor M Meidan; Michael C Bonner; Bozena B Michniak
Journal:  Int J Pharm       Date:  2005-11-02       Impact factor: 5.875

7.  On-line diffusion profile of a lipophilic model dye in different depths of a hair follicle in human scalp skin.

Authors:  Ylva Y Grams; Lynne Whitehead; Gerda Lamers; Nico Sturmann; Joke A Bouwstra
Journal:  J Invest Dermatol       Date:  2005-10       Impact factor: 8.551

8.  Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles.

Authors:  Alexa Teichmann; Ute Jacobi; Michael Ossadnik; Heike Richter; Stefan Koch; Wolfram Sterry; Jürgen Lademann
Journal:  J Invest Dermatol       Date:  2005-08       Impact factor: 8.551

9.  Interactions of oleic acid and model stratum corneum membranes as seen by 2H NMR.

Authors:  Amy C Rowat; Neil Kitson; Jenifer L Thewalt
Journal:  Int J Pharm       Date:  2005-11-15       Impact factor: 5.875

10.  Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery.

Authors:  Ebtessam A Essa; Michael C Bonner; Brian W Barry
Journal:  J Pharm Pharmacol       Date:  2002-11       Impact factor: 3.765

View more
  6 in total

1.  The Delivery of α1-Antitrypsin Therapy Through Transepidermal Route: Worthwhile to Explore.

Authors:  Srinu Tumpara; Beatriz Martinez-Delgado; Gema Gomez-Mariano; Bin Liu; David S DeLuca; Elena Korenbaum; Danny Jonigk; Frank Jugert; Florian M Wurm; Maria J Wurm; Tobias Welte; Sabina Janciauskiene
Journal:  Front Pharmacol       Date:  2020-07-03       Impact factor: 5.810

2.  Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.

Authors:  Cedar H A Boakye; Ketan Patel; Mandip Singh
Journal:  Int J Pharm       Date:  2015-04-21       Impact factor: 5.875

3.  Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma.

Authors:  Chandraiah Godugu; Ravi Doddapaneni; Apurva R Patel; Rakesh Singh; Roger Mercer; Mandip Singh
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

Review 4.  Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy.

Authors:  Palanivel Ganesan; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2016-05-11

Review 5.  pH-Responsive Polypeptide-Based Smart Nano-Carriers for Theranostic Applications.

Authors:  Rimesh Augustine; Nagendra Kalva; Ho An Kim; Yu Zhang; Il Kim
Journal:  Molecules       Date:  2019-08-15       Impact factor: 4.411

Review 6.  Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications.

Authors:  Yi-Qun Yu; Xue Yang; Xiao-Fang Wu; Yi-Bin Fan
Journal:  Front Bioeng Biotechnol       Date:  2021-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.